secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-05-27T12:30:16+00:00
Accession:  0001493152-26-025338
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies announces Mexican patent allowance for CyPath Lung cancer detection method
--------------------------------------------------------------------------------

- Mexican patent allowance for flow-cytometry methods to detect lung cancer using CyPath Lung.
- Patent will protect use of defined antibodies and TCPP porphyrin to label sputum cells.
- CyPath Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy, 99% NPV in trial.
- IP portfolio now includes patents in US, EU, China, Japan, Australia, Canada, and Mexico.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226025338/0001493152-26-025338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226025338/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-025338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer